| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702319 | Surgical Oncology | 2017 | 9 Pages |
Abstract
These data suggest that neoadjuvant treatment with gemcitabine/nab-paclitaxel is a safe and effective option for potentially resectable PA compared with the SF approach.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Benedetto Ielpo, Riccardo Caruso, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Luis Malavé, Valentina Ferri, Rafael Alvarez, Antonio Cubillo, Carlos Plaza, Sara Lazzaro, Denis Kalivaci, Yolanda Quijano, Emilio Vicente,